The 2nd Copenhagen Symposium on Separation Sciences (CSSS 2018)
The 2nd Copenhagen Symposium on Separation Sciences (CSSS 2018) will be held at DGI-Byen Hotel, Copenhagen, Denmark, from 26–27 June 2018.
Photo Credit: Bucchi Francesco/shutterstock.com
The 2nd Copenhagen Symposium on Separation Sciences (CSSS 2018) will be held at DGI-Byen Hotel, Copenhagen, Denmark, from 26–27 June 2018.
The Copenhagen Symposium on Separation Sciences is the meeting point where separation scientists from the pharmaceutical industry, academia, and vendors interact. The scientiï¬c programme has been designed accordingly, featuring 18 invited plenary lectures by internationally leading scientists, submitted posters presented by participants, discussion sessions, and dinner. In addition, an exhibition of instruments, equipment, and consumables is an important and integrated part of the scientiï¬c programme. The invited talks by leading scientists will provide perspective, fundamentals, insight, and glimpses of how the field of separation sciences is developing.
Scientific sessions will include: the long-term perspective; recent progress in liquid-phase chromatography and electrophoresis; recent progress in microfluidics; recent progress in immunoaffinity techniques; forefront applications of mass spectrometry; forefront biopharmaceutical characterization; and ADME and pharmacometabolomics.
The first CSSS was organized in June 2016 with close to 100 participants. This very successful symposium was initiated by Professor Steen Honoré Hansen from the University of Copenhagen. Steen was a pioneer in separation sciences applied to pharmaceutics, but unfortunately, he passed away on 31 October 2017. The CSSS series will be organized to honour Steen and his great contribution to separation science.
For more information, please visit our web page at https://cphsss.org
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
